These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5950876)

  • 1. Tumour ploidy and prognosis in carcinomas of the bladder and prostate.
    Tavares AS; Costa J; de Carvalho A; Reis M
    Br J Cancer; 1966 Sep; 20(3):438-41. PubMed ID: 5950876
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARCINOMA ORIGINATING IN DUCTS SURROUNDING THE PROSTATIC URETHRA.
    ENDE N; WOODS LP; SHELLEY HS
    Am J Clin Pathol; 1963 Aug; 40():183-9. PubMed ID: 14060023
    [No Abstract]   [Full Text] [Related]  

  • 4. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of prognosis in superficial bladder cancer.
    Fradet Y
    Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
    [No Abstract]   [Full Text] [Related]  

  • 6. Urothelial carcinoma of the prostate.
    Goebbels R; Amberger L; Wernert N; Dhom G
    Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA banding patterns in carcinoma of the bladder.
    Falor WH; Ward RM
    JAMA; 1973 Dec; 226(11):1322-7. PubMed ID: 4128146
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative scanning: evaluation for metastatic disease in carcinoma of the breast, lung, colon, bladder, and prostate.
    Smalley RV; Malmud LS; Ritchie WG
    Semin Oncol; 1980 Dec; 7(4):358-69. PubMed ID: 7008200
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
    Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteral obstruction in simultaneous carcinoma of the prostate and the bladder.
    Shah N; Shuman I; Seitzman DM
    Int Surg; 1976 Feb; 61(2):117-8. PubMed ID: 1254400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostatic urothelial location of a tumor of the bladder].
    Coulange C; Lechevallier E; de Fromont M
    Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
    Cao S
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.